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γδ T cells reside predominantly at barrier sites and play essential roles in immune protection against 
infection and cancer. Despite recent advances in the development of γδ T cell immunotherapy, our 
understanding of the basic biology of these cells, including how their numbers are regulated in vivo, 
remains poor. This is particularly true for tissue-resident γδ T cells. We have identified the β2 family 
of integrins as novel regulators of γδ T cells. β2 integrin-deficient mice displayed a striking increase 
in numbers of IL-17-producing Vγ6Vδ1+ γδ T cells in the lungs, uterus and circulation. Thymic 
development of this population was normal. However, single cell RNA sequencing revealed the 
enrichment of genes associated with T cell survival and proliferation specifically in β2 integrin-
deficient IL-17+ cells compared to their WT counterparts. Indeed, β2 integrin-deficient Vγ6+ cells 
from the lungs showed reduced apoptosis ex vivo, suggesting that increased survival contributes 
to the accumulation of these cells in β2 integrin-deficient tissues. Furthermore, our data revealed 
an unexpected role for β2 integrins in promoting the thymic development of the IFNγ-producing 
CD27+ Vγ4+ γδ T cell subset. Together, our data reveal that β2 integrins are important regulators of 
γδ T cell homeostasis, inhibiting the survival of IL-17-producing Vγ6Vδ1+ cells and promoting the 
thymic development of the IFNγ-producing Vγ4+ subset. Our study indicates new and 
unprecedented mechanisms of control for γδ T cell subsets. 
 
Significance Statement 
γδ T cells reside in barrier tissues and provide immune protection against infection and cancer. 
Their anti-tumor potential has led to recent advances in the development of γδ T cell 
immunotherapy. However, our understanding of the basic biology of these cells, including what 
molecules and pathways control their maintenance within barrier tissues, remains poor. We 
demonstrate that β2 integrin adhesion molecules play a major role in regulating γδ T cell subset 
numbers during homeostasis: the loss of β2 integrin expression results in a striking increase in IL-
17-producing γδ T cells in the lungs and uterus due to enhanced survival. These findings illustrate 













γδ T cells are innate-like cells that play essential roles in immune surveillance, neonatal immunity 
and responses to infection and tumors. Tissue-resident γδ T cells localize within barrier sites such 
as the skin, gut, lungs, genital tract and oral mucosa, enabling rapid responses against infectious 
challenge without the need for clonal expansion. Upon recognition of foreign antigens, host stress-
induced markers or innate-derived cytokines (1-3), γδ T cells mediate immune protection via direct 
killing of target cells and production of pro-inflammatory cytokines, IFNγ and IL-17.  
γδ T cells are the major innate source of IL-17 during the early phase of an immune response (4). 
Mouse models have demonstrated protective roles for IL-17-producing γδ T cells in a range of 
mucosal infections (5-7). In humans, IL-17-producing γδ T cells have been reported in cord blood 
(8) and can be expanded from PBMCs in vitro (9, 10). Although their contribution to infection-driven 
immune responses remains poorly described, IL-17-producing γδ T cell numbers are increased in 
patients with bacterial meningitis (10), suggesting an important role. 
We set out to explore the regulatory roles of β2 integrins in γδ T cell populations that reside in barrier 
tissues. β2 integrins are leukocyte-specific adhesion molecules that consist of the β2 chain (CD18) 
coupled to CD11a (αL), CD11b (αM), CD11c (αX) or CD11d (αD). It is well characterized that 
Leukocyte Function-associated Antigen-1 (LFA-1; CD11a/CD18) is essential for many aspects of 
αβ T cell function (11): by binding intercellular adhesion molecules (ICAMs) on endothelial cells 
LFA-1 mediates T cell recruitment to lymph nodes (LN) and sites of inflammation; LFA-1 localizes 
to the immunological synapse between interacting T and antigen-presenting cells, stabilizing 
contacts and lowering the threshold for T cell activation; T cell LFA-1 mediates interactions with 
target cells (e.g. B cells or cancerous/infected cells) facilitating effector T cell functions. However, 
the involvement of β2 integrins in γδ T cell recruitment, interactions and function is less well defined 
(reviewed in (12)). Whilst some reports demonstrate a role for β2 integrins in mediating γδ T cell 
interactions with endothelial cells (13), γδ T cell trafficking to sites of inflammation can occur 





Evidence suggests that β2 integrins control γδ T cell numbers and/or localization: under conditions 
of skin and periodontal inflammation in CD18-deficient (CD18hypo PL/J) and CD11a knockout (KO) 
mice, respectively, increased numbers of γδ T cells were found at inflamed sites (15, 16). Even in 
the absence of overt inflammation, increased proportions and/or numbers of γδ T cells have been 
reported in the cervical LNs (17), spleen and mesenteric LNs (18) of CD18 KO mice. Based on this 
evidence, we hypothesized that β2 integrins regulate γδ T cell numbers during homeostasis and 
inflammation. However, these studies have been limited in the tissues analyzed, making it unclear 
if the alterations in cell number are due to expansion or redistribution. Additionally, γδ T cell 
numbers, subset profiles and phenotype at barrier sites (e.g. lungs, small intestine, uterus, gingiva), 
where these cells have major immune protective roles, have not been analyzed in β2 integrin-
deficient mice. 
In this study we investigated the impact of β2 integrin-deficiency on γδ T cell subset numbers, 
localization and phenotype. We demonstrate that loss of β2 integrin expression leads to a tissue-
restricted increase in IL-17-producing Vγ6Vδ1+ γδ T cells that is prominent in the lungs, uterus and 
spleen. We also reveal a novel role for β2 integrins in promoting thymic development of IFNγ-




β2 integrin-deficient mice have a tissue-restricted increase in γδ T cells 
γδ T cell numbers were quantified in a range of lymphoid and mucosal tissues from β2 integrin-
deficient (CD18 KO) mice. αβ T cells were analyzed for comparison. γδ T cell numbers were 
increased in the lungs, uterus, spleen and blood of CD18 KO mice, whereas numbers in the skin 
(includes both dermis and epidermis), oral mucosa, gut and other lymphoid tissues were unaffected 
by β2 integrin loss (Fig. 1; gating shown in SI Appendix, Fig. S1). As anticipated, αβ T cell numbers 
were reduced in the LNs, Peyer’s patches and bone marrow, as a result of defective homing (19, 





that the increase in γδ T cells in CD18 KO mice is not due to redistribution but, instead, a tissue-
specific expansion. 
 
β2 integrin loss leads to an increase in IL-17-producing γδ T cells 
γδ T cells are broadly divided into two mutually exclusive phenotypes based on cytokine profile: 
IFNγ-producing cells and IL-17-producing cells. Splenic γδ T cells from CD18 KO mice produced 
significantly higher levels of IL-17 as both proportion and absolute numbers compared to WT cells 
(Fig. 2A-B). Increased IL-17 was observed across the tissues where γδ T cell numbers were 
increased (Fig. 2B). The enhanced numbers of IL-17-producing γδ T cells in CD18 KO mice 
contributed to an increase in serum IL-17 levels (SI Appendix, Fig. S2A-B). Despite the apparent 
defect in the percentage of IFNγ-producing CD18 KO γδ T cells (Fig. 2A), the number of IFNγ-
producing γδ T cells was equivalent (Fig. 2B). 
 
The expanded γδ T cell population in β2 integrin-deficient mice express the Vγ6Vδ1 TCR 
Next, we questioned whether the expanded γδ T cell population was due to an increase in one or 
more γδ T cell subsets in β2 integrin-deficient mice. Murine γδ T cell subsets express different Vγ 
chains, numbered Vγ1-7 (Heilig and Tonegawa nomenclature (21)), which localize to specific 
tissues and have different capacity for cytokine production (22). We predicted that CD18 KO mice 
would have an increase in Vγ4+ and/or Vγ6+ γδ T cells, as these subsets are the predominant IL-
17-producers (23). Vγ chain expression was initially analyzed using antibodies against Vγ1, Vγ4 
and Vγ5. Despite proportional differences in multiple subsets (SI Appendix, Fig. S3A), calculation 
of absolute numbers revealed a significant increase only in the Vγ1-Vγ4-Vγ5- γδ T cells in CD18 KO 
mice (Fig. 2C). This was true for all tissues where an increase was previously found in total γδ T 
cell numbers (Fig. 1 and Fig. 2C). PCR analysis of the ‘unknown’ Vγ1-Vγ4- population in CD18 KO 
mice revealed expression of the Vγ6 and Vδ1 TCR chains (Fig. 2D; SI Appendix, Fig. S3B). Note 





frame transcript expression, and high RNA level may reflect poor allelic exclusion (24). Extensive 
flow cytometric analysis confirmed that CD18 KO splenic γδ T cells displayed a marker phenotype 
consistent with IL-17-producing cells: they were predominantly CD62Llo, CD44hi, CD27-, CD45RB- 
and Rorγt+ (SI Appendix, Fig. S3C), suggestive of IL-17 production (25, 26); and they expressed 
higher levels of CD3 and TCRγδ than their WT counterparts (SI Appendix, Fig. S3C), a phenotype 
that implies a Vγ6-expressing phenotype (27). Together, these data show that the absence of β2 
integrin expression leads to an increase in IL-17-producing γδ T cells that express the Vγ6Vδ1 
TCR. 
 
The increase in IL-17-producing γδ T cells is due to loss of LFA-1 
β2 integrins are a family of four receptors, the loss of one or more of which could cause the γδ T 
cell expansion seen in CD18 KO mice. Analysis of CD11 chain KO mice revealed that the increase 
in γδ T cell numbers was due to the specific loss of LFA-1, as increased numbers of γδ T cells were 
detected in the spleen and lungs of CD11a KO mice but not in mice lacking CD11b, CD11c or 
CD11d (SI Appendix, Fig. S4A). We confirmed that the enhanced capacity to produce IL-17 was 
also observed in the expanded γδ T cell population in CD11a KO mice (SI Appendix, Fig. S4B). 
 
Thymic development of Vγ6+ γδ T cells is unaffected by β2 integrin loss, whilst CD27+Vγ4+ γδ T cell 
development is impaired 
We next sought to investigate the mechanism of expansion of Vγ6+ IL-17-producing γδ T cells in 
β2 integrin-deficient mice. Vγ6+ γδ T cells egress from the thymus from embryonic 16.5 (E16.5) to 
a few days after birth and are, thereafter, maintained in the periphery by self-renewal (28). Analysis 
of the thymus showed equivalent numbers of Vγ6+ γδ T cells in WT and CD18 KO mice in 
embryonic, neonatal (1 and 3 day old), and adult (4 week old) mice (Fig. 3A). As thymic output of 
Vγ6+ cells both at the peak of development and in adult mice was normal, we conclude that the 





Surprisingly, whilst Vγ1+ and Vγ5+ γδ T cell development was also equivalent in WT and CD18 KO 
mice, we found a reduction in the number of thymic Vγ4+ γδ T cells in embryonic and neonatal mice 
(Fig. 3A). Further analysis to differentiate between immature and mature populations revealed that 
the reduced number of total Vγ4+ cells was due to a loss of immature CD24+ cells at E18.5, and 
then mature CD24- Vγ4+ cells in 4 week old mice (Fig. 3B). This suggests that the loss of β2 integrin 
expression impairs Vγ4+ γδ T cell development from the early, immature stage. The number of Vγ6+ 
cells, regardless of maturation status, was similar in the thymus of WT and CD18 KO mice, further 
confirming that Vγ6+ γδ T cell development is unaffected by β2 integrin loss. 
IL-17- and IFNγ-producing γδ T cells can be distinguished by expression of CD27, which is present 
only on IFNγ-producers (25). Further analysis revealed that numbers of CD27+ Vγ4+ cells in the 
thymus were reduced in CD18 KO mice across all ages of mice analyzed (Fig. 3C). No differences 
were found in CD27- Vγ4+ cells. These data suggest that β2 integrin loss causes a specific defect 
in the development of CD27+ Vγ4+ γδ T cells that have the potential to produce IFNγ. 
To determine whether this impaired development impacts on the numbers of Vγ4+ cells in the 
periphery, tissues were analyzed in adult mice. We previously showed that the number of Vγ4+ 
cells was equivalent in CD18 KO mice at sites where the expanded Vγ6+ cells were found (lungs, 
uterus, spleen and blood) (Fig. 2C). However, as Vγ4+ cells commonly reside within lymphoid 
tissues, we performed a more thorough examination. The number of Vγ4+ cells was significantly 
decreased in the peripheral LNs (inguinal, brachial and axillary pooled). A similar trend of reduced 
Vγ4+ cell numbers was observed in the mediastinal LN and bone marrow, but this did not reach 
statistical significance (Fig. 3D). These findings indicate that the impaired development of Vγ4+ γδ 
T cells in CD18 KO mice results in reduced numbers of these cells specifically in the peripheral 
LNs. 
 





Next, single cell RNA sequencing (scRNAseq) was used to investigate the possible mechanism(s) 
by which β2 integrins control γδ T cell numbers in the periphery. Principal component analysis of 
lung γδ T cells revealed 5 biologically distinct clusters: the Il17a+ cluster which contains both Vγ6+ 
(Cd163l1+ Trdv4+) and Vγ4+ (5830411N06Rik+) cells, two Cd27+ clusters namely Ccr7+ and Ly6c2+, 
and much smaller clusters of killer cells (Gzma+) and dividing cells (Cdk6+) (Fig. 4A; SI Appendix, 
Fig. S5A-C). As expected, the CD18 KO cells were over-represented in the Il17a+ cluster (Fig. 4B). 
High expression of the Vγ6 (Tcrg-V6) and Vδ1 (Trdv4) TCR subunits as well as Scart1 (Cd163l1), 
confirmed the expanded CD18 KO population as Vγ6+ cells (SI Appendix, Fig. S5D). The number 
of differentially expressed (DE) genes when comparing WT to KO was much greater in the Il17a+ 
cluster (1439 genes) than the Ccr7+ (74 genes) or Ly6c2+ (32 genes) clusters (Fig. 4C; Dataset 
S1A-C). We determined the DE genes that were unique to the IL-17-producing population (Fig. 4C; 
Dataset S2), excluding DE genes dependent on the loss of the β2 integrin which were common to 
2 or 3 of the dominant γδ T cell populations. Pathway analysis revealed enrichment of genes 
associated with T cell activation, survival and proliferation in CD18 KO cells from the IL-17-
producing cluster (Fig. 4D; SI Appendix, Fig. S5E; Dataset S3). Specifically, the pro-survival genes 
Bcl2a1a and Bcl2a1d, known to support the survival of skin-resident Vγ6+ cells (29), were uniquely 
enriched in CD18 KO Il17a+ γδ T cell cluster (Fig. 4E; SI Appendix, Fig. S5E). Other genes reported 
to enhance survival in T cells (TCR subunits and signaling molecules, the IL-2 receptor, Cd44 and 
Icos) as well as in cancer cells (Crip1) (30) were also enriched in the CD18 KO Il17a+ cluster (Fig. 
4E; SI Appendix, Fig. S5E). Together, scRNAseq analysis revealed the dysregulation of pathways 
involved in cell survival and proliferation specifically in the CD18 KO IL-17-producing γδ T cell 
population. 
 






Assessing proliferation in vivo, we detected a small but significant increase in Ki67 expression in 
Vγ6+ cells from both the spleen and lungs of CD18 KO mice compared to WT (Fig. 5A). However, 
we found similar incorporation of BrdU by WT or CD18 KO Vγ6+ or Vγ4+ cells in either tissue over 
the 7-day period of analysis (Fig. 5B), suggesting that β2 integrin-deficient Vγ6+ cells do not show 
enhanced proliferation in adult mice. This data is supported by the scRNAseq analysis which shows 
that CD18 KO cells are not enriched in the dividing Cdk6+ cluster (Fig. 4B), and by GO enrichment 
analysis where pathways associated with apoptosis dominated (Fig. 4D).  
Next, we sought to determine whether cell survival is influenced by β2 integrin deficiency. Detailed 
analysis of tissues from CD18 KO mice of various ages revealed that Vγ6+ γδ T cell numbers in the 
lungs and spleen were equivalent to WT mice at E18.5, when this population begins to egress the 
thymus (Fig. 6A; SI Appendix, Fig. S6A). However, at 1-day post-birth, CD18 KO mice show 
increased numbers of Vγ6+ γδ T cells in the lungs, and from 3-day old mice onwards, the numbers 
in the spleen were also elevated. Interestingly, whilst Vγ6+ γδ T cell numbers in the lungs reach a 
plateau from day 3, numbers in the spleen of CD18 KO mice continue to rise as the mice age, 
increasing to 40-fold more than WT at 4 weeks (Fig. 6A). Surface marker analysis confirmed that 
the expanded γδ T cell population displayed the expected CD45RB- CD44+ CD27- phenotype 
consistent with IL-17-producing potential (SI Appendix, Fig. S6B). These data indicate that the 
increased number of Vγ6+ γδ T cells initially arise in the lungs and then the spleen. The 
accumulation of cells over time is consistent with enhanced Vγ6+ cell survival in CD18 KO mice. 
IL-7 is known to drive T cell survival through Bcl2 (31). As Il7r was expressed at higher levels in 
CD18 KO cells compared to WT in the Il17a+ cluster (SI Appendix, Fig. S5D) and “cellular response 
to IL-7” was a hit in pathway analysis (Dataset S3), we assessed expression of IL-7R and Bcl2 in 
lung γδ T cells. Expression of IL-7R was higher in Vγ6+ cells compared to Vγ4+ cells but was 
equivalent between WT and CD18 KO cells (SI Appendix, Fig. S7A). Bcl2 expression was also 
equivalent in WT and CD18 KO γδ T cells (SI Appendix, Fig. S7B). Thus, signaling through the IL-





Next, we investigated the effect of β2 integrin loss on γδ T cell survival by direct ex vivo analysis. 
Vγ6+ γδ T cells from the lungs of CD18 KO mice displayed reduced apoptosis compared to WT, 
with increased proportion of live cells and reduced proportion of late apoptotic cells (Fig. 6B). This 
effect was specific to the Vγ6+ cells, as the proportions of live and apoptotic cells in the Vγ4+ 
population were equivalent. Furthermore, the enhanced survival of CD18 KO cells was specific to 
the lungs, as cells in the spleen showed similar levels of apoptosis regardless of genotype or subset 
(Fig. 6B). Of note, this enhanced survival was most apparent in 4-week-old mice (Fig. 6C) as well 
as adult mice (Fig. 6B), whereas viability of Vγ6+ cells in neonatal mice was equivalent in WT and 
CD18 KO mice (Fig. 6C). Thus, the enhanced survival of lung Vγ6+ cells, particularly in adult mice, 
likely contributes to the accumulation of this γδ T cell subset in CD18 KO mice. 
 
LFA-1 expression is higher in Vγ6+ cells compared to Vγ4+ cells, particularly in the lungs, in WT 
mice 
Finally, we questioned why β2 integrin loss led to the selective expansion of the Vγ6+ subset.  
Assessment of β2 integrin expression in γδ T cells revealed only CD11a (LFA-1) and not CD11b or 
CD11c expression (SI Appendix, Fig. S8). In the lungs, expression of CD11a was highest in the 
Vγ6+ population compared to Vγ1+ and Vγ4+ cells, whereas γδ T cell populations expressed 
equivalent, lower levels of CD11a in the spleen (Fig. 6C). CD11a expression was equivalent across 
γδ T cell populations in the pLN (SI Appendix, Fig. S8) where Vγ6+ cell numbers are unaffected by 
CD18 deficiency (Fig. 3D). These data suggest that Vγ6+ γδ T cells in the lungs may be most 




In this study we reveal that the absence CD18 expression in mice leads to a striking increase in 





spleen. Vγ6+ cells showed no difference in thymic development or proliferation but displayed a 
transcriptional profile consistent with enhanced survival and reduced levels of apoptosis ex vivo. 
Surprisingly, we also found that β2 integrin loss impaired the development of IFNγ-producing 
(CD27+) Vγ4+ γδ T cells, leading to reduced numbers of this subset in peripheral LNs. Together, 
our findings highlight novel roles for β2 integrins in promoting Vγ4+ γδ T cell development and in 
negatively regulating Vγ6+ γδ T cell numbers in the periphery via apoptosis. In doing so, β2 integrins 
alter the balance between IL-17- and IFNγ-producing γδ T cells at mucosal and lymphoid sites. 
Importantly, we found no defect in γδ T cell numbers in any tissue, showing conclusively that the 
increase in γδ T cell numbers reported here and in previous studies in integrin-deficient mice (17, 
18) is not a redistribution effect but a tissue-specific increase in γδ T cells that occurs in the absence 
of LFA-1. In agreement with previous studies (14, 15), our findings indicate that homing of γδ T 
cells to an extensive range of mucosal and lymphoid tissues is not dependent on β2 integrins. 
It was unsurprising that the increase in γδ T cell numbers was most apparent in the lungs and 
uterus (in addition to the spleen), as Vγ6+ cells preferentially localize to these tissues (26, 32). 
However, Vγ6+ cells also reside in the dermis (33) and gingiva (34), where no differences were 
found. Analysis of whole skin (epidermis and dermis) may have masked any differences exclusive 
to the dermis. In addition, there may be stronger competition by other skin-resident T cells, 
precluding accumulation of Vγ6+ cells in the dermis. Alternatively, the expanded Vγ6+ γδ T cell 
population in CD18 KO mice may be truly tissue specific. Vγ6+ cells are not described to 
preferentially home to the spleen, although they have been shown to reside there (26, 27). We 
propose that the increasing number of Vγ6+ cells exceeds the capacity within their resident tissues 
(lungs and uterus), which forces the γδ T cells into the circulation and causes accumulation in the 
spleen. The enhanced number of γδ T cells in the blood and appearance of increased numbers in 
the lungs prior to the spleen in newborn mice support this. 
Analysis of CD18hypo mice (CD18 expression at 2-16% of WT) revealed the expanded γδ population 
in the skin to have a CD27- IL-17+ phenotype (15). The authors reported expression of Vγ4 rather 





potential difference in Vγ chain expression in CD18 KO mice versus CD18hypo mice could be due 
to genetic differences (C57BL/6J versus PL/J backgrounds), the level of CD18 expression (absent 
versus low), or changes induced by inflammation (no overt inflammation in our CD18 KO mice; 
severe dermatitis in the CD18hypo mice (15)). 
Although thymic development of Vγ6+ cells was unaffected by β2 integrin loss, we found an 
unexpected defect in Vγ4+ cell development. The defect was specific to the IFNγ-producing CD27+ 
Vγ4+ cells. The loss of CD18 impacts early in Vγ4+ γδ T cell development (fewer immature Vγ4+ 
cells at E18.5) but is not absolutely necessary, as the Vγ4+ cells are reduced in number but not 
completely ablated. Interestingly, the numbers of Vγ4-expressing γδ T cells were only reduced in 
the peripheral LNs of adult CD18 KO mice and not the spleen or lungs where this population also 
resides. This may indicate that migration of Vγ4+ cells to peripheral LNs is partially dependent on 
β2 integrins or that factors present in the spleen and lungs but absent in peripheral LNs 
preferentially expand or retain Vγ4+ cells. The functional consequences of the reduced numbers of 
Vγ4+ cells in peripheral LNs of CD18 KO mice remains to be determined. As IFNγ production by 
Vγ4+ cells is protective in models of melanoma (35, 36) and viral infection (37), reduced numbers 
of Vγ4+ cells may enhance pathology in these models. 
Our study highlights survival, rather than proliferation, as the dominant mechanism of Vγ6+ cell 
accumulation in adult CD18 KO mice. We did find a slight but significant increase in Ki67 expression 
in Vγ6+ cells from CD18 KO mice, potentially indicating longer time spent in active cell cycle (38), 
whilst not progressing to proliferation. Indeed, by BrdU incorporation we found little evidence of 
active γδ T cell proliferation regardless of genotype, which fits with published reports showing low 
turnover of Vγ6+ cells in adult mice (33, 39). Although it is possible that CD18 KO cells may be 
undergoing increased proliferation compared to WT at a slow rate not detected, the scRNAseq 
analysis shows a very small population of dividing (Cdk6+) γδ T cells, the frequency of which is 
unaltered in CD18 KO mice. Whilst it remains possible that proliferation contributes to an increase 
in Vγ6+ cells in neonatal mice, our data illustrate that survival is the major contributor to Vγ6+ 





scRNAseq analysis of lung γδ T cells revealed a striking enrichment of genes associated with 
survival, specifically in the β2 integrin-deficient Vγ6+ γδ T cells. Importantly, ex vivo analysis 
confirmed that Vγ6+ cells from the lungs of CD18 KO mice displayed decreased apoptosis 
compared to WT. Several TCR components as well as molecules downstream of the TCR signaling 
pathway (Cd44, Icos, Lat, Nr4a1 (Nur77)) were increased in CD18 KO Vγ6+ cells, suggesting that 
TCR signaling may contribute to the pro-survival phenotype. Although ligands that drive the 
expansion and retention of Vγ5+ and Vγ7+ γδ T cells have been characterized, namely Skint1 (40) 
and Btnl1 (41) respectively, a ligand specific for Vγ6+ cells has not yet been identified. If such a 
ligand exists, an upregulation in CD18 KO lungs and uterus may contribute to the expansion 
phenotype seen in this study. Furthermore, two members of the Bcl2a1 family (Bcl2a1a, Bcl2a1d), 
that have been reported to support the survival of skin-resident Vγ6+ cells (29), were also enhanced 
in our CD18 KO lung Vγ6+ cells. Therefore, it is likely that a combination of signaling pathways that 
promote cell survival contribute to the accumulation of Vγ6+ cells in β2 integrin-deficient mice. 
One remaining question is why the increase in γδ T cells is restricted to the Vγ6-expressing subset. 
β2 integrins expressed by γδ T cells may contribute directly to the induction of apoptosis (42). As 
we found LFA-1 expression to be highest in Vγ6+ cells in the lungs, this may explain the specificity 
of survival of the Vγ6+ subset in LFA-1-deficient mice. 
Although not definitive from our study, a cell-intrinsic role for LFA-1 in suppressing γδ T cell 
apoptosis is supported by the following evidence: (i) γδ T cell expansion was dependent on the loss 
of LFA-1 but no other β2 integrin family members; (ii) in our hands, γδ T cells highly expressed LFA-
1 but no other CD11 subunits; (iii) the expansion of γδ T cells was apparent in the tissues of CD18 
KO mice from 1 day post-birth when other lymphocyte populations are still developing (e.g. very 
few αβ T cells are present); and (iv) the increase in γδ T cells was first observed in the lungs where 
stromal populations (negative for LFA-1) rather than leukocytes predominate. We, therefore, 
propose a model where LFA-1, potentially in conjunction with TCR and/or death receptor signaling, 





The functional consequences of the expanded IL-17-producing γδ T cell population in β2 integrin-
deficient mice remain to be determined. IL-17-producing γδ T cells are known to be required for 
effective pathogen clearance, particularly in the lungs and uterus (5-7, 43), and yet contribute to 
pathology in models of autoimmune disorders (44, 45) and cancer (46). We would predict that the 
expanded Vγ6+ cell population will alter outcome in these immune challenge models in an IL-17-
dependent manner. 
Although a subset equivalent to the Vγ6+ γδ T cells identified in mice does not exist in humans, 
future analysis of Vδ1- and Vδ2-expressing subsets, both of which have been shown to produce 
IL-17, may reveal a potential role for β2 integrins in regulating specific subsets of human γδ T cells. 
The targeting of IL-17-producing γδ T cells has been identified as a therapeutic strategy for patients 
with spondyloarthritis (47), therefore further work to elucidate the role of β2 integrins in the 
regulation human γδ T cells may reveal novel targets for therapy.  
In summary, our findings reveal unanticipated roles for the β2 integrin, LFA-1, in regulating the 
balance between IL-17- and IFNγ-producing γδ T cell subsets: β2 integrins promote the 
development of IFNγ-producing CD27+ Vγ4+ cells in the thymus, whilst suppressing the survival of 
IL-17-producing CD27- Vγ6+ cells in the periphery. The striking expansion of Vγ6+ cells in β2 
integrin-deficient mice demonstrates the central role this integrin plays in regulating this elusive γδ 
T cell population. The impact of these and other adhesion molecules on the survival and phenotype 
of γδ T cells should be carefully considered when developing cancer therapeutics to target the 
immuno-protective functions of this lymphocyte population. 
 
 
Materials and Methods 
 
Mice 
CD18 (#003329) KO mice were purchased from The Jackson Laboratory. Age and sex-matched 





used as controls. Mice were housed at the University of Glasgow. All protocols were conducted 
under licenses issued by the U.K. Home Office under the Animals (Scientific Procedures) Act of 
1986 and approved by the local ethics committee.  
Tissue Processing 
Single cell suspensions were prepared from spleen, thymus, mesenteric LNs, mediastinal LNs, 
peripheral LNs (inguinal, brachial and axillary pooled) and Peyer’s patches by mashing between 
45µm NITEX pieces (Cadisch Precision Meshes Ltd.). Cells were isolated from bone marrow by 
flushing using a 26G needle. Spleen, blood and bone marrow cell suspensions were lysed with 
RBC lysis buffer (eBioscience). Uterus’ were digested using Multi Dissociation Kit 1 (Miltenyi 
Biotec) according to the manufacturer’s instructions. Ear skin was digested in 2mg/ml Collagenase 
IV, 2mg/ml hyaluronidase (both Sigma-Aldrich), and 100 U/ml DNase I (Invitrogen) at 37°C for 40 
min at 180 RPM in a rotating incubator, then dissociated using a gentlemacs (Miltenyi Biotec). The 
following tissues were digested as described: lungs(48), small intestine(49), gingiva(50). Cells were 
counted by trypan blue exclusion. 
Flow cytometry 
Details of flow cytometry antibodies can be found in the SI Appendix. Cells were stained with fixable 
viability dye eFluor506 (eBioscience) for 30mins at 4°C. Extracellular staining was performed in Fc 
block (supernatant from 2.4G2 cell line) for 30mins at 4°C. For intracellular cytokine staining, cells 
were stimulated with 10ng/ml PMA (Sigma Aldrich), 500ng/ml ionomycin (Sigma Aldrich) and 
1:1000 GolgiPlug (BD Biosciences) for 4h at 37°C. Following extracellular staining, cells were fixed 
using Cytofix/Cytoperm and stained in Perm/Wash (both BD Biosciences). For transcription factor 
staining, cells were fixed using FoxP3 Transcription Factor Fixation/Permeabilisation buffer and 
stained in permeabilization buffer (both eBioscience). All intracellular staining was for 1hr at room 
temperature (RT). For apoptotic cell staining, cells were stained with AnnexinV (Biolegend) and 





suspended in FACS buffer (PBS 2% FBS 2mM EDTA) and acquired on LSRII or LSR Fortessa (BD 
Biosciences). Data was analyzed using Flowjo software (Treestar).  
Fluorescence-activated cell sorting 
γδ T cells from CD18 KO spleens were pre-enriched using EasySepTM Mouse T cell Isolation Kit 
(Stemcell Technologies). Live, CD3+TCRγδ+, Vγ1-Vγ4- cells were then sorted using a FACS Aria 
IIU (BD Biosciences).  
RNA isolation, cDNA and PCR 
RNA was purified using RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. 
cDNA synthesis was carried out using High-Capacity RNA-to-cDNA Kit (Applied Biosystems). Vγ 
and Vδ chain sequences were amplified using 0.02U/µl, 1X Phusion HF buffer, 3% DMSO, 2mM 
MgCl2 (Vγ6 reaction only) (all Thermo Fisher), 0.2mM dNTPs (Invitrogen) and 0.3µM primers (IDT 
Technologies). Primer sequences for Vγ1, Vγ4, Vγ5, Vγ6 and Vγ7 were kindly provided by Dr Pierre 
Vantourout (King’s College London) and for Vγ2 and Vδ have been described(51). DNA fragments 
were separated on 1% agarose (Invitrogen) gels and visualized using Gel DocTM XR+ system 
(BioRad).  
Single cell RNA sequencing 
γδ T cells were isolated from the lungs of 2 WT mice and 1 CD18 KO mouse by FACS-sorting for 
CD3+ TCRγδ+ cells. Single cell suspensions were loaded into a Chromium Controller (10X 
Genomics). Subsequently, cDNA was generated from polyadenylated RNA, amplified and 
converted to Illumina compatible libraries according to standard protocol published in Single Cell 
3’ Reagent Kits v3 User Guide (10X Genomics). These were sequenced on an Illumina 
NextSeq500 sequencer with a sequencing depth of approximately 50,000 read pairs per cell. The 
read 1 and 2 were 28bp and 91bp long, respectively. scRNAseq reads were mapped in Cellranger 
(version 3.1.0) (52) against the current Mus musculus reference (mm10-3.0.0). The obtained 
readcount matrixes were analyzed in Seurat (53), version 3.1.2 in R version 3.5.3. We followed the 





mitochondria amount less than 18% and applied the nFeature_RNA a cut-off of 2200, 3200 and 
2500 cells for WT1, WT2 and KO, respectively. To remove technical variation, we used the 
SCtransform protocol in Seurat. WT1 and KO samples were integrated first, and then WT2 added 
which was down sampled to 4000 cells. The number of PCA transformation dimensions was 15; 
and the “findcluster” resolution was 0.15. Marker genes were selected for cluster annotation, non-
T cell clusters removed, and clustering then repeated. The default Seurat values (FindMarkers 
function) were used to determine differentially expressed (DE) genes, with an adjusted p-value cut-
off of 0.01. Venny 2.1 (bioinfogp.cnb.csic.es/tools/venny/) was used to compare DE genes in 
different clusters. GO enrichment pathway analysis was performed in Panther (pantherdb.org/). 
The reads and read counts are available in ArrayExpress under the accession number E-MTAB-
8732. Furthermore, we designed a cell atlas to query the data, which can be accessed via this link: 
http://cellatlas.mvls.gla.ac.uk/gdT-cell/  This cell atlas was programmed in R-shiny using the Seurat 
pipeline as describe above. 
Statistical analysis 
Student’s t test or two-way ANOVA (Graphpad Prism) were used to calculate statistical 
significance. Sidak’s multiple comparisons test was used to correct for multiple comparison. P 
values shown as ns not significant, *p<0.05, **p<0.01, ***p<0.005, ****p<0.0001.  
 
 
Data Availability Statement 
 
The reads and read counts from the single cell RNA sequencing are available in ArrayExpress 
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are included in the main text or SI Appendix. Further information about data and reagents used is 
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Fig. 1. CD18 KO mice have increased numbers of γδ T cells in the lungs, uterus, spleen and 
blood. Cells were isolated from various lymphoid and mucosal tissues of WT (open circles) and 
CD18 KO (closed circles) mice then analyzed by flow cytometry. Skin includes both dermis and 
epidermis. Cells were gated on CD3+ then TCRβ+ or TCRγδ+ as shown in SI Appendix, Fig. S1. 
Absolute number of αβ and γδ T cells per tissue is shown. For blood, numbers were calculated per 
100µl. SI = small intestine; mLN = mesenteric LNs; pLN = peripheral LNs (brachial, axillary and 





represents and individual mouse. Statistical differences were determined using a two-way ANOVA 
*p<0.05, **p<0.01, ****p<0.0001. 
 
Fig. 2. IL-17-producing Vγ6Vδ1+ γδ T cells are increased in CD18 KO mice. (A) Representative 
plot showing percentage of IL-17+ and IFNγ+ γδ T cells from WT and CD18 KO spleen following in 
vitro stimulation with PMA/ionomycin/BfA for 4h. (B) Number of IL-17+ and IFNγ+ γδ T cells from 
the lungs, uterus and spleen of WT and CD18 KO mice following in vitro stimulation with 
PMA/ionomycin/BfA for 4h. n=9 pooled from 3 independent experiments. (C) Cells isolated from 
WT and CD18 KO tissues were analyzed for Vγ chain expression by flow cytometry. Samples were 
gated on CD3+TCRγδ+ then Vγ1+, Vγ4+, Vγ5+ or Vγ1-Vγ4-Vγ5-. Absolute number of each Vγ subset.  
n=10 pooled from 4 independent experiments. (D) CD18 KO splenocytes were sorted by FACS for 
CD3+ TCRγδ+ Vγ1- Vγ4- cells then RNA isolated and RT-PCR performed. Representative gels 
showing expression of Vγ and Vδ genes. Representative of n=4. Positive controls for each Vγ and 
Vδ chain are shown in SI Appendix, Fig. S3C. Statistical differences were determined using a two-




Fig. 3. CD18 KO mice show no difference in Vγ6+ thymic development but have impaired 
development of Vγ4+ γδ T cells. (A-C) Thymocytes were analyzed from E18.5, 1 day, 3 day and 
4 week old WT and CD18 KO mice by flow cytometry. Samples were gated on CD3+TCRγδ+ then 
Vγ1+, Vγ4+, Vγ5+ or Vγ1-Vγ4-Vγ5- (Vγ6+). (A) Absolute number of each Vγ subset. (B) Absolute 
number of Vγ4+ and Vγ6+ cells gated on either immature CD24+ (left) or mature CD24- (right). (C) 
Absolute number of mature CD24- Vγ4+ γδ T cells gated on either CD27+ or CD27-. (D) Absolute 
number of Vγ4+ and Vγ6+ γδ T cells from lymphoid tissues of adult mice. pLN = peripheral lymph 
nodes (inguinal, brachial and axillary pooled); medLN = mediastinal lymph node; mLN = mesenteric 
lymph nodes. (A-C) n=6-11 pooled from a minimum of 3 independent experiments. (D) pLN, mLN 
and bone marrow n=9, data pooled from 3 independent experiments. medLN n=6, data pooled from 
2 independent experiments. Each symbol represents an individual mouse. Statistical differences 
were determined using a two-way ANOVA. *p<0.05, **p<0.01, and ***p<0.001. 
 
Fig. 4. Single cell RNA sequencing reveals enhanced expression of genes known to 
negatively regulate apoptosis, specifically in Vγ6+ cells from CD18 KO mice. γδ T cells were 
purified from the lungs of 2 WT and 1 CD18 KO mice by FACS. scRNAseq was performed and 
data analyzed as described in detail in the Materials and Methods section. The number of cells 
sequenced were: WT1, 918 cells; WT2, 6315 cells; KO, 4034 cells.  (A) Principal component 
analysis plot showing the 5 identified clusters. (B) Frequency of cells in each of the identified 
clusters. (C) Venn diagram showing the shared and unique differentially expressed genes between 
WT and KO in the 3 major clusters, namely Il17a+, Ccr7+ and Ly6c2+. (D) The apoptosis pathways 
identified in GO enrichment analysis of the differentially expressed genes unique to the Il17a+ 
cluster. Fold enrichment and p-value are shown for each pathway. +ve = positive; -ve = negative; 
reg. = regulation; PCD = programmed cell death. (E) Expression levels of selected genes identified 






Fig. 5. No evidence of enhanced proliferation in Vγ6+ γδ T cells from CD18 KO mice. (A) Cells 
isolated from the spleen and lungs of WT and CD18 KO mice were stained for the expression of 
Ki67. Representative histograms are shown from the spleen. Pooled data shows n=6 from 2 
independent experiments. (B) WT and CD18 KO mice were injected with 1mg BrdU i.p. then fed 
0.8mg/ml BrdU in the drinking water for 7 days. Cells isolated from the spleen and lungs were 
analyzed by flow cytometry for expression of BrdU. Representative histograms are shown from the 
spleen. Pooled data shows n=6 from 2 independent experiments. +ve = positive control (thymus). 
Each symbol represents an individual mouse. Statistical differences were calculated using a two-
way ANOVA, *p<0.05, **p<0.01. 
 
Fig. 6. CD18 KO Vγ6+ γδ T cells display enhanced survival. (A) Analysis of γδ T cells from the 
lungs and spleen of WT and CD18 KO mice at various ages. Cells were gated on CD3+ TCRγδ+ 
then Vγ1+, Vγ4+, Vγ5+ or Vγ1-Vγ4-Vγ5- (Vγ6+). Absolute number of Vγ6+ (Vγ1-Vγ4-Vγ5-) γδ T cells 
is shown. Where significant differences between WT and CD18 KO were found, the fold difference 
is shown. WT spleen & lungs at 3 day old n=6. CD18 KO spleen at 1 day old, WT/CD18 KO lungs, 
WT/CD18 KO spleen at 4 week old, WT lungs 4 week old n=7. WT spleen at 1 day old n=8. CD18 
KO spleen at 3 day old, CD18 KO lungs 3 days/4 weeks old, WT spleen E18.5 n=10. CD18 KO 
spleen & lungs E18.5 n=11. Data pooled from 4-6 litters, with each litter run as an independent 
experiment, each symbol represents an individual mouse. Statistical differences were determined 
using a Student’s t test with false discovery rate approach two-stage linear step-up procedure of 
Benjamini, Krieger and Yekutieli. (B) Cells isolated from adult WT and CD18 KO lungs and spleen 
were analyzed by flow cytometry for expression of apoptosis markers. Cells were gated on CD3+ 
TCRγδ+ then Vγ4+ or Vγ1-Vγ4- (Vγ6+). Proportions of Vγ6+ or Vγ4+ γδ T cells that were live (Annexin 
V- 7AAD-), early apoptotic (Annexin V+ 7AAD-) or late apoptotic (Annexin V+ 7AAD+) are shown. 
Graphs show n=9 pooled from 3 independent experiments; each symbol represents an individual 
mouse. (C) Viable cells (staining negative for viability dye) were calculated in each γδ T cell subset 
at various ages of mice. N is as described in (A). (D) CD11a expression in lung and spleen γδ T 
cell subsets was quantified by flow cytometry. n=8; 3 independent experiments. Statistical 
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